Concepts (66)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| ATP-Binding Cassette Transporters | 4 | 2015 | 120 | 1.610 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2015 | 115 | 1.130 |
Why?
|
| Cholesterol | 3 | 2013 | 331 | 1.040 |
Why?
|
| Alzheimer Disease | 3 | 2011 | 565 | 0.550 |
Why?
|
| Lipid Metabolism | 2 | 2013 | 186 | 0.510 |
Why?
|
| Sphingosine | 1 | 2015 | 315 | 0.420 |
Why?
|
| Biological Transport | 2 | 2011 | 210 | 0.400 |
Why?
|
| Cell Membrane | 1 | 2013 | 525 | 0.400 |
Why?
|
| Receptors, LDL | 1 | 2011 | 72 | 0.380 |
Why?
|
| Sphingolipids | 1 | 2013 | 337 | 0.360 |
Why?
|
| Neuroblastoma | 1 | 2011 | 109 | 0.360 |
Why?
|
| Amyloid beta-Peptides | 1 | 2010 | 191 | 0.330 |
Why?
|
| Hybrid Cells | 1 | 2008 | 18 | 0.320 |
Why?
|
| Androstenes | 1 | 2008 | 6 | 0.320 |
Why?
|
| Anticholesteremic Agents | 1 | 2008 | 49 | 0.310 |
Why?
|
| Peptide Fragments | 1 | 2010 | 483 | 0.310 |
Why?
|
| Up-Regulation | 1 | 2010 | 682 | 0.310 |
Why?
|
| Cell Line, Tumor | 4 | 2015 | 1851 | 0.300 |
Why?
|
| Neurons | 1 | 2011 | 881 | 0.260 |
Why?
|
| RNA, Messenger | 3 | 2015 | 1664 | 0.220 |
Why?
|
| Mice | 5 | 2015 | 8474 | 0.220 |
Why?
|
| Esterification | 2 | 2013 | 25 | 0.210 |
Why?
|
| Signal Transduction | 1 | 2011 | 2689 | 0.200 |
Why?
|
| Animals | 5 | 2015 | 20881 | 0.150 |
Why?
|
| Genes, jun | 1 | 2015 | 13 | 0.130 |
Why?
|
| Upstream Stimulatory Factors | 1 | 2015 | 6 | 0.120 |
Why?
|
| Ceramidases | 1 | 2015 | 47 | 0.120 |
Why?
|
| Rats | 2 | 2013 | 5300 | 0.120 |
Why?
|
| Acetyl-CoA C-Acetyltransferase | 1 | 2013 | 2 | 0.120 |
Why?
|
| Biological Transport, Active | 1 | 2013 | 49 | 0.120 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 99 | 0.110 |
Why?
|
| Repressor Proteins | 1 | 2015 | 183 | 0.110 |
Why?
|
| Protein Kinase C | 1 | 2015 | 270 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 615 | 0.110 |
Why?
|
| Membrane Lipids | 1 | 2011 | 31 | 0.100 |
Why?
|
| Homeostasis | 1 | 2011 | 291 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 434 | 0.080 |
Why?
|
| Transfection | 1 | 2011 | 782 | 0.080 |
Why?
|
| Humans | 7 | 2015 | 68618 | 0.080 |
Why?
|
| Gene Expression | 1 | 2011 | 770 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 284 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2008 | 2673 | 0.050 |
Why?
|
| Genetic Techniques | 1 | 2002 | 32 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2002 | 320 | 0.050 |
Why?
|
| Risk Factors | 1 | 2011 | 5731 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2002 | 498 | 0.040 |
Why?
|
| Foot Diseases | 1 | 1999 | 20 | 0.040 |
Why?
|
| Orthotic Devices | 1 | 1999 | 28 | 0.040 |
Why?
|
| Fasciitis | 1 | 1999 | 30 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 492 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 852 | 0.010 |
Why?
|
| Heel | 1 | 1999 | 5 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 1753 | 0.010 |
Why?
|
| Physical Therapy Modalities | 1 | 1999 | 133 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 2077 | 0.010 |
Why?
|
| Pain Management | 1 | 1999 | 186 | 0.010 |
Why?
|
| Algorithms | 1 | 2002 | 1196 | 0.010 |
Why?
|
| Pain | 1 | 1999 | 472 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1999 | 3705 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1999 | 4848 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 1999 | 7029 | 0.000 |
Why?
|
| Aged | 1 | 1999 | 14862 | 0.000 |
Why?
|
| Middle Aged | 1 | 1999 | 21147 | 0.000 |
Why?
|
| Adult | 1 | 1999 | 21403 | 0.000 |
Why?
|
| Male | 1 | 1999 | 37321 | 0.000 |
Why?
|
| Female | 1 | 1999 | 38074 | 0.000 |
Why?
|